Axogen Corporation
Clinical trials sponsored by Axogen Corporation, explained in plain language.
Axogen Corporation
AXGN
NASDAQ
A medical device company focused on peripheral nerve repair and regeneration.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Nerve cap aims to ease pain after limb loss Results expected Dec 2026 (estimated)
- New wrap may shield nerves during second elbow surgery Results expected Dec 2026 (estimated)